Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000230906 | SCV000290592 | likely benign | Charcot-Marie-Tooth disease axonal type 2C | 2024-12-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000235250 | SCV000293905 | uncertain significance | not provided | 2024-11-20 | criteria provided, single submitter | clinical testing | Reported as a variant of uncertain significance in two individuals with Charcot-Marie-Tooth disease in published literature (PMID: 32376792); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Observed in homozygous state in one clinically unaffected adult relative of an individual referred for genetic testing at GeneDx; This variant is associated with the following publications: (PMID: 32906206, 32376792) |
Molecular Genetics Laboratory, |
RCV001173243 | SCV001336325 | uncertain significance | Charcot-Marie-Tooth disease | criteria provided, single submitter | clinical testing | ||
Mayo Clinic Laboratories, |
RCV000235250 | SCV001716142 | uncertain significance | not provided | 2019-05-26 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002379021 | SCV002696435 | likely benign | Inborn genetic diseases | 2019-11-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Revvity Omics, |
RCV000235250 | SCV003821543 | uncertain significance | not provided | 2020-04-29 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004547612 | SCV004117152 | uncertain significance | TRPV4-related disorder | 2023-06-15 | criteria provided, single submitter | clinical testing | The TRPV4 c.1378C>T variant is predicted to result in the amino acid substitution p.Arg460Trp. This variant was reported in two individuals with Charcot-Marie-Tooth disease. However, segregation information was not provided and the variants clinical significance was classified as uncertain (Volodarsky et al 2021. PubMed ID: 32376792). This variant is reported in 0.024% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/12-110232247-G-A). At this time, we interpret this variant's clinical significance as uncertain due to the absence of conclusive functional and genetic evidence. |
Ce |
RCV000235250 | SCV004700713 | likely benign | not provided | 2024-09-01 | criteria provided, single submitter | clinical testing | TRPV4: BS2 |